Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03792698 · ClinicalTrials.gov registry record · NA
Preventing Rehospitalization in Lung Transplant Recipients Utilizing mHealth
A NA study of Lung Transplant; Complications, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT03792698 is a NA study of Lung Transplant; Complications that has completed, run by University of Pennsylvania. The registered enrollment target is 30 participants, below the 571-participant average among 6 other Lung Transplant; Complications trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03792698, a NA study of Lung Transplant; Complications, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
Lung transplantation has several important aims: 1) extend survival; 2) relieve disability, and 3) improve health-related quality of life (HRQL) for adults suffering from end-stage lung disease. Advances in medical therapies and changes in the US organ allocation system in 2005 have prioritized lung transplant for sicker and older patients. This achievement has come at substantial cost, including recent trends in recipients towards increased disability, poorer health-related quality of life, and increased longer-term mortality. Additionally, lung transplant recipients have the highest risk of unexpected readmission after the index admission, with published rates of 40-43%. Frailty at the time of discharge is one of the leading factors for readmission. The investigator's belief is that improving access to individualized exercise training plans that are modified based on a patient's progress and needs will greatly improve a transplant recipient's level of physical fitness and independence, and decrease the risk of hospital readmission. This will lead to an overall improvement in a patient's quality of life.
Conditions Studied
Interventions
- OTHER Aidcube digital app-based platform
Study Locations (2)
California
- University of California San Francisco - San Francisco
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03792698
The ClinicalTrials.gov registry entry for NCT03792698 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 571-participant average among 6 other Lung Transplant; Complications trials with a reported enrollment target (95% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Transplant; Complications appearing as the primary indexed condition, and to 1 intervention - of which Aidcube digital app-based platform is the first listed.
NCT03792698 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03792698 about?
NCT03792698 is a clinical study titled "Preventing Rehospitalization in Lung Transplant Recipients Utilizing mHealth". Lung transplantation has several important aims: 1) extend survival; 2) relieve disability, and 3) improve health-related quality of life (HRQL) for adults suffering from end-stage lung disease. Advances in medical therapies and changes in the US organ allocation system in 2005 have prioritized lung...
What is the current status of trial NCT03792698?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-01-15. Estimated completion is 2020-06-01.
What conditions does trial NCT03792698 study?
This clinical trial studies the following conditions: Lung Transplant; Complications.
What interventions are being tested in trial NCT03792698?
The interventions under investigation include: Aidcube digital app-based platform (OTHER).
Who is sponsoring clinical trial NCT03792698?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03792698 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplant; Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
ACTIVE NOT RECRUITING · NA
-
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
RECRUITING · Early Phase 1
-
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
RECRUITING
-
CMV Immunity Monitoring in Lung Transplant Recipients
RECRUITING · Phase 2
-
AlloSure Lung Assessment and Metagenomics Outcomes Study
ACTIVE NOT RECRUITING
-
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.